Drug Pricing Executive Action Is Unlikely: Evercore ISIMark Melin
There is significant chatter in Washington D.C. that U.S. President Barack Obama could use his executive authority to regulate drug pricing, a “flash note” from Evercore ISI analyst Terry Haines says. But such an action is unlikely for three primary reasons, says the research note delivered to institutional investors earlier Wednesday.
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.